Surfactant therapy for acute lung injury and other lung diseases

O. Rosenberg, A. Bautin, V. Osovskich, I. Kozlov, V. V. Erochin, O. Lovacheva, L. Lepekha, A. Seiliev, A. Volchkov, V. Poptsov (S Petersburg, St Petersburg, Moscow, Russia)

Source: Annual Congress 2003 - Third ERS – free paper symposium on interdisciplinary basic and clinical surfactant research
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Rosenberg, A. Bautin, V. Osovskich, I. Kozlov, V. V. Erochin, O. Lovacheva, L. Lepekha, A. Seiliev, A. Volchkov, V. Poptsov (S Petersburg, St Petersburg, Moscow, Russia). Surfactant therapy for acute lung injury and other lung diseases. Eur Respir J 2003; 22: Suppl. 45, 1429

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surfactant therapy for post-bypass lung injury
Source: Eur Respir J 2002; 20: Suppl. 38, 35s
Year: 2002

The impact of corticosteroid on the inflammatory mediators in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2007 - Acute lung injury and inflammation
Year: 2007


Mechanisms of acute lung injury
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004


The association between LASSBio596 and surfactant improves lung morpho-function and reduces the inflammatory process in experimental sepsis-induced acute lung injury
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010

Ventilator-induced lung injury
Source: Eur Respir J 2003; 22: 2S-9S
Year: 2003



The role of pendrin in acute lung injury caused by ventilator-induced lung injury
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020

Pulmonary disease as a risk factor for transfusion-related acute lung injury
Source: ERJ Open Res, 7 (3) 00039-2021; 10.1183/23120541.00039-2021
Year: 2021



Mechanisms responsible for surfactant changes in sepsis-induced lung injury
Source: Eur Respir J 2005; 26: 1074-1079
Year: 2005



Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury in lung transplantation
Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation
Year: 2004

When to start surfactant therapy (ST-therapy) of acute lung injury?
Source: Eur Respir J 2001; 18: Suppl. 33, 7s
Year: 2001

Acute exacerbations of progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180071; 10.1183/16000617.0071-2018
Year: 2018



Delayed neutrophil apoptosis may predispose to lung injury in chronic lung disease of prematurity
Source: Eur Respir J 2007; 30: Suppl. 51, 393s
Year: 2007

Development of inhalation therapy for prevention and treatment of acute lung injury
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010


Acute lung injury: how the lung inflammatory response works
Source: Eur Respir J 2003; 22: 22S-23S
Year: 2003


Diffuse parenchymal lung diseases presenting with acute hypoxemic failure 
Source: International Congress 2017 – Pulmonary emergencies year in review
Year: 2017


Ventilator-associated lung injury: a search for better therapeutic targets
Source: Eur Respir J 2007; 30: 1216-1226
Year: 2007